
- AeroClean Technologies Inc's (NASDAQ:AERC) Pūrgo technology has secured U.S. FDA 510(k) clearance, classifying it as a Class II Medical Device.
- The clearance was granted following examination of the patented Pūrgo device, which utilizes patented germicidal UV-C LED air purification technology that has been proven to eliminate 99.99% of harmful airborne microorganisms, including bacteria, fungi, and viruses, like COVID-19.
- The patented technology uses hospital-grade HEPA filtration and optimized germicidal UV irradiation to provide supplemental, localized air cleaning and enhanced ventilation.
- AeroClean provides healthcare facilities, businesses, hospitality venues, and government agencies with medical-grade air purification and air sanitization technology.
- Price Action: AERC shares are trading higher by 39.7% at $3.33 on the last check Monday.